Microginon (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol and Levonorgestrel, the active ingredients in Microginon, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy in women of reproductive age by suppressing ovulation and altering cervical mucus.

GNH USA supplies Microginon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Microginon, a combined oral contraceptive, is used to prevent pregnancy by modulating the hormonal axis.

- Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing age. - Menstrual cycle regulation: helps achieve more predictable menstrual bleeding patterns. - Acne improvement: can reduce acne associated with androgen excess.

Microginon may cause a range of adverse reactions. Most are mild and transient, but serious events can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like. - Breast tenderness: discomfort or swelling. - Spotting or irregular bleeding: especially during the first months. - Weight gain: modest increase in body weight. - Mood changes: irritability or mood swings.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to the lungs. - Stroke: cerebrovascular accident due to clot or hemorrhage. - Myocardial infarction: heart attack risk in susceptible individuals. - Severe allergic reaction (anaphylaxis): rapid onset of hives, swelling, breathing difficulty. - Liver tumor: rare benign hepatic adenoma.

Before prescribing Microginon, clinicians should evaluate several safety aspects.

- Thromboembolic risk assessment: avoid in women with history of clotting disorders. - Blood pressure monitoring: contraindicated in uncontrolled hypertension. - Smoking status: caution in smokers over 35 years of age. - Cancer history review: avoid in estrogen‑dependent tumor history. - Breastfeeding counseling: discuss benefits and risks if used during lactation. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Microginon can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy. - Rifampin: markedly decreases hormone levels. - Griseofulvin: may lower effectiveness of the pill. - Certain antiretroviral protease inhibitors (e.g., ritonavir): can increase hormone concentrations. - St. John’s wort: herbal inducer that diminishes contraceptive protection.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may raise estrogen levels. - SSRIs (e.g., fluoxetine): can increase bleeding tendency. - Thiazide diuretics: may exacerbate hypertension. - Herbal supplements (e.g., ginseng): potential metabolic interaction. - High‑dose vitamin C: may elevate estrogen exposure.